首页> 外国专利> Hl-2 PROTEIN DERIVED FROM HAEMAPHYSALIS LONGICORNIS HAVING BLOOD CLOTTING INHIBITION ACTIVITY

Hl-2 PROTEIN DERIVED FROM HAEMAPHYSALIS LONGICORNIS HAVING BLOOD CLOTTING INHIBITION ACTIVITY

机译:具有血凝抑制活性的血红蛋白Hl-2蛋白

摘要

PROBLEM TO BE SOLVED: To provide a new protein having blood clotting inhibition activity. SOLUTION: The present invention provides an Hl-2 protein which is a new protein derived from Haemaphysalis longicornis and provide an Hl-2 gene encoding the protein. The Hl-2 protein has blood clotting inhibition activity and, accordingly, pharmaceuticals containing the Hl-2 protein as an active component are useful as a blood clotting inhibition agent for the treatment and prevention of myocardial infarction, pulmonary infarction and cerebral infarction. The Hl-2 protein is highly expectable also in the field for the development of pharmaceuticals as a leading compound of a blood clotting inhibitor.
机译:要解决的问题:提供一种具有凝血抑制活性的新蛋白质。解决方案:本发明提供了一种H1-2蛋白,其是一种来自长血ema的新蛋白,并提供了编码该蛋白的H1-2基因。 H1-2蛋白具有凝血抑制活性,因此,含有H1-2蛋白作为活性成分的药物可用作治疗和预防心肌梗塞,肺梗塞和脑梗塞的凝血抑制剂。在药物开发中,作为血液凝结抑制剂的主要化合物,H1-2蛋白也是高度期望的。

著录项

  • 公开/公告号JP2003116569A

    专利类型

  • 公开/公告日2003-04-22

    原文格式PDF

  • 申请/专利权人 MIE UNIV;

    申请/专利号JP20010317155

  • 申请日2001-10-15

  • 分类号C12N15/09;A61K38/00;A61P7/02;C07K14/435;

  • 国家 JP

  • 入库时间 2022-08-22 00:16:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号